nach oben

Erschienen in:

01.08.2011

Recurrent pancreatic carcinoma and cholangiocarcinoma: ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

verfasst von: Katherine Cameron, Sivan Golan, William Simpson, Steven Peti, Sasan Roayaie, Daniel Labow, Lale Kostakoglu

Erschienen in: Abdominal Radiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Although the current literature is limited, available data suggest that ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

Jemal A, Siegel R, Ward E, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225PubMedCrossRef

American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117:1463–1484 (1999)

West J, Wood H, Logan RF, Quinn M, Aithal GP (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer 94(11):1751–1758PubMedCrossRef

Khan SA, Taylor-Robinson SD, Toledano MB, Elliott Beck A, Thomas HC P (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumors. J Hepatol 37(6):806–813PubMedCrossRef

Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 3(2):10CrossRef

Nehls O, Gregor M, Klump B (2004) Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 24(2):139–154PubMedCrossRef

National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology, Hepatobiliary cancers. Version 2

Huang QJ, Xu Q, Wang XN, et al. (2002) Spiral multi-phase CT in evaluating resectability of pancreatic carcinoma. Hepatobiliary Pancreat Dis Int 1(4):614–619PubMed

Tamm EP, Loyer EM, Faria S, et al. (2006) Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 31(5):568–574

10.

Diehl SJ, Lehmann KJ, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206:373–378PubMed

11.

McCarthy MJ, Evans J, Sagar G, et al. (1998) Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 85:320–325PubMedCrossRef

12.

Ohtani T, Shirai Y, Tsukada K, et al. (1993) Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology 189:875–880PubMed

13.

Ward EM, Stephens DH, Sheedy PF (1983) Computed tomographic characteristics of pancreatic carcinoma: an analysis of 100 cases. Radiographics 3:547–565.

14.

Solomon R (2009) Contrast-induced acute kidney injury (CIAKI). Radiol Clin North Am 47(5):783–788PubMedCrossRef

15.

Sperti C, Pasquali C, Bissoli S, et al. (2010) Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastrointest Surg 14(1):131–140PubMedCrossRef

16.

Casneuf V, Delrue L, Kelles A, et al. (2007) Is combined 18F-flurodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Acta Gastroenterol Belg 70(4):331–338PubMed

17.

Ruf J, Lopez Hanninen E, Oettle H, et al. (2005) Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology 5(2–3):266–272PubMedCrossRef

18.

Rose DM, Delbeke D, Beauchamp RD, et al. (1998) 18-Fluorodeoxyglucose-positron emission tomography (18FDG-PET) in the management of patients with suspected pancreatic cancer. Ann Surg 229:729–738CrossRef

19.

Franke C, Klapdor R, Meyerhoff K, Schauman M (1999) 18-F Positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res 19:2437–2442PubMed

20.

Jadvar H, Fischman AJ (2001) Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging 26(3):254–259PubMedCrossRef

21.

Kim J, Quon A, Humke E, Ford JM, Koong AC (2009) Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT. Clin Nucl Med 34(5):312–313PubMedCrossRef

22.

Corvera CU, Blumgart LH, Akhurst T, et al. (2008) ¹⁸F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206:57–65PubMedCrossRef

23.

Jadvar H, Henderson RW, Conti PS (2007) (18F) fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr 31:223–228PubMedCrossRef

24.

Peters PE, Beyer K (1985) Normal lymph node cross-sections in different anatomic regions and their significance for computed tomographic diagnosis. Radiologe 25:193–198PubMed

25.

Dorfman RE, Alpern MB, Gross BH, Sandler MA (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 180:319–322PubMed

26.

Lucey BC, Stuhlfaut JW, Soto JA (2005) Mesenteric lymph nodes: detection and significance on MDCT. Am J Roentgenol 184:41–44

27.

Pansky B (1990) Anatomy of the pancreas. Emphasis on blood supply and lymphatic drainage. Int J Pancreatol. 7(1–3):101–108

28.

Donatini B, Hidden G (1992) Routes of lymphatic drainage from the pancreas: a suggested segmentation. Surg Radiol Anat 14(1):35–42PubMedCrossRef

29.

Weber SM, Jarnagin WR, Klimstra D, et al. (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193(4):384–391PubMedCrossRef

30.

Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S (2001) Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8(2):154–157PubMedCrossRef

31.

Castaing D (2008) Surgical anatomy of the biliary tract. HPB 10:72–76PubMedCrossRef

32.

Diederichs CG, Staib L, Vogel J, et al. (2000) Values, limitations of ¹⁸F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109PubMedCrossRef

33.

Shreve PD (1998) Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 25:259–264PubMedCrossRef

34.

Diederichs CG, Staib L, Glasbrenner B, et al. (1999) F-18 Fluorodeoxyglucose (FDG) and C-reactive protein (CRP). Clin Pos Imaging 2:131–136CrossRef

35.

Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277–1285PubMedCrossRef

36.

Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30(11):1467–1472PubMedCrossRef

37.

Anderson CD, Rice MH, Pinson CW, et al. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. Gastrointest Surg 8(1):90–97CrossRef

38.

Li TR, Tian JH, Wang H, Chen ZQ, Zhao CL F (2009) Pitfalls in positron emission tomography/computed tomography imaging: causes and their classifications. Chin Med Sci J 24(1):12–19PubMedCrossRef

39.

Zimny M, Bares R, Fass J, et al. (1997) Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 24:678–682PubMed

40.

Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ (2004) PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24(5):1411–1431PubMedCrossRef

Titel: Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)
verfasst von: Katherine Cameron
Sivan Golan
William Simpson
Steven Peti
Sasan Roayaie
Daniel Labow
Lale Kostakoglu
Publikationsdatum: 01.08.2011
Verlag: Springer-Verlag
Erschienen in: Abdominal Radiology / Ausgabe 4/2011
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-011-9729-6

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recurrent pancreatic carcinoma and cholangiocarcinoma: ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

Abstract

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

MR imaging features of uterine adenomyomas

Laparoscopic sleeve gastrectomy: a guide to postoperative anatomy and complications

Diagnosis of Budd–Chiari syndrome: three-dimensional dynamic contrast enhanced magnetic resonance angiography

Comment on “Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy”

Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation

Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie